Top Versus Top: Valley National Bancorp (NYSE:VLY), Puma Biotechnology Inc (NASDAQ:PBYI)

Valley National Bancorp (NYSE:VLY)

Valley National Bancorp (NYSE:VLY) closed at $10.82 on the last trading session with an increase of 1.12%, whereas, it previously closed at $10.7. The company has a market capitalization of $4.49 Billion. The company traded shares of 1.71 Million on the trading day while its three month average volume stands at 2.06 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Valley National Bancorp (NYSE:VLY) produced diluted EPS of 0.78. The EPS estimate for next year as estimated by analysts is at 1.01 while EPS for next quarter is estimated at 0.26. Earnings per Share growth for this year is reported at 17.9, while the analysts estimated the EPS growth for next year at 1.01% and Earnings growth for next 5 years stands at 5% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 9.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Valley National Bancorp (NYSE:VLY) is at 13.91 while the forward p/e is at 10.76. The P/S or Price to Sales ratio of Valley National Bancorp (NYSE:VLY) stands at 3.22 and Price to Book or P/B for the most recent quarter stands at 1.01. The Price to Free Cash Flow ratio or P/FCF is reported at 5.38. The quick ratio and the current ratio of Valley National Bancorp (NYSE:VLY) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Valley National Bancorp (NYSE:VLY) stands at 0.8, 7.3 and 14.9 respectively

The trailing twelve month Revenue of Valley National Bancorp (NYSE:VLY) is reported at 1.39 Billion with income of 310.7 Million. The outstanding shares of Valley National Bancorp (NYSE:VLY) are 403.83 Million. The institutional Ownership of the shares of 60.7 stands at 0.80%, this figure is increased 0.18 in the last six months. The insider ownership for the shares of Valley National Bancorp (NYSE:VLY) is ticked at 0.2%, the figure is plummeted -0.68% in the last six months.

Some other important financial aspects to be discussed here for Valley National Bancorp (NYSE:VLY) is the Mean Target Price estimated by the analysts which stands at 11. The 52 week high of Valley National Bancorp (NYSE:VLY) is placed at 11.52 and 52 week low is standing at 6.00.

Performance wise the shares of Valley National Bancorp (NYSE:VLY) rose up 10.07% for the week, it also rise 10.86% for the monthly performance, while for the quarter it went down 40.16%. The shares increase 54.46% for the half year and flew up for the Year-To-Date performance. The shares of Valley National Bancorp (NYSE:VLY) shrinked -3.31% for the yearly performance.

Puma Biotechnology Inc (NASDAQ:PBYI)

Puma Biotechnology Inc (NASDAQ:PBYI) closed at $11.36 on the last trading session with an decrease of -1.3%, whereas, it previously closed at $11.51. The company has a market capitalization of $442.02 Million. The company traded shares of 323933 on the trading day while its three month average volume stands at 569 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Puma Biotechnology Inc (NASDAQ:PBYI) produced diluted EPS of -1.43. The EPS estimate for next year as estimated by analysts is at -1.02 while EPS for next quarter is estimated at -0.28. Earnings per Share growth for this year is reported at 34.9, while the analysts estimated the EPS growth for next year at -1.02% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 16.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Puma Biotechnology Inc (NASDAQ:PBYI) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Puma Biotechnology Inc (NASDAQ:PBYI) stands at 1.88 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Puma Biotechnology Inc (NASDAQ:PBYI) are reported at 1.3 and 1.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Puma Biotechnology Inc (NASDAQ:PBYI) stands at -22.8, -451.5 and -56.5 respectively

The trailing twelve month Revenue of Puma Biotechnology Inc (NASDAQ:PBYI) is reported at 235.5 Million with income of -56200000. The outstanding shares of Puma Biotechnology Inc (NASDAQ:PBYI) are 39.7 Million. The institutional Ownership of the shares of 96 stands at 0.80%, this figure is increased 0.05 in the last six months. The insider ownership for the shares of Puma Biotechnology Inc (NASDAQ:PBYI) is ticked at 11.1%, the figure is plummeted -1.04% in the last six months.

Some other important financial aspects to be discussed here for Puma Biotechnology Inc (NASDAQ:PBYI) is the Mean Target Price estimated by the analysts which stands at 10.33. The 52 week high of Puma Biotechnology Inc (NASDAQ:PBYI) is placed at 15.00 and 52 week low is standing at 5.50.

Performance wise the shares of Puma Biotechnology Inc (NASDAQ:PBYI) rose up 6.67% for the week, it also rise 6.12% for the monthly performance, while for the quarter it went down 16.16%. The shares increase 13.6% for the half year and flew up for the Year-To-Date performance. The shares of Puma Biotechnology Inc (NASDAQ:PBYI) grew 47.34% for the yearly performance.